Recce Pharmaceuticals (R9Q.F) Q1 2026 Earnings

27FebConfirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
-0.04
-0.03
-0.02
-0.02

Details

Expected EPS
N/A
Actual EPS
-0.0323569475775
Surprise EPS
-0.03
Surprise Percent
+∞%

Description

Recce Pharmaceuticals (R9Q.F) has reported earnings of -0.0323569475775 per share for Q1 2026.

0 Comments

Share your thoughts